Scenarios that move RMD
ResMed Inc. Common Stock
Scenarios that move RMD: 4 analyses, 1 positive, 3 negative.
- · Zealand Pharma reports positive survodutide Phase III weight loss results — ▼ · impact -25 · confidence low · horizon quarters
- · Novo Nordisk's Ozempic outperforms Lilly's Mounjaro on cardiovascular risk — ▲ · impact +12 · confidence low · horizon quarters
- · Lilly reports strong weight loss results for new drug — ▼ · impact -35 · confidence low · horizon quarters
- · Viking Therapeutics stock skyrockets in Tuesday trading — ▼ · impact -15 · confidence low · horizon quarters